METHOD FOR TREATING TUBERCULOSIS OF LUNGS WITH THE ADVANCED RESISTANCE OF MYCOBACTERIA TOWARDS ANTITUBERCULOUS DRUGS WITHIN INTENSIVE PHASE OF CHEMOTHERAPY

摘要

A method for treating tuberculosis of the lungs with the advanced resistance of mycobacteria towards antituberculous drugs within the intensive phase of chemotherapy provides for the daily use of five antituberculous drugs at the average daily doses, including those drugs of line I-II (primary agents) that are still effective against mycobacteria according to sensitivity assay with additional back-up drugs. In addition, 2-3 primary drugs to which mycobacteria are resistant are included into the treatment regimen: Pirasinamide and/or Etambutol and/or Protionamide and/or PASA.